What is Methemoglobinemia?
Methemoglobinemia is a congenital or acquired blood disorder caused by an abnormal amount of methemoglobin which is a form of hemoglobin.
Hemoglobin is the protein in red blood cells (RBCs) responsible for carrying and distributing oxygen through the body. Methemoglobinemia occurs when the RBCs contain methemoglobin at levels higher than 1%. When this happens, there is a decreased availability of oxygen to the body tissues.
If methemoglobin levels rise above 15%, neurological and cardiac issues occur due to hypoxia. Levels above 70% are usually fatal.
Methemoglobinemia can be inherited, congenital or acquired (exposure to certain drugs, chemicals or foods).
There are two forms of inherited methemoglobinemia namely autosomal recessive methemoglobinemia and autosomal dominant methemoglobinemia
1, In autosomal recessive methemoglobinemia both the parents carry the gene but do not express the condition. The enzyme cytochrome b5 reductase is responsible for this form.
There are two types of autosomal recessive methemoglobinemia:
- Type 1 (erythrocyte reductase deficiency) occurs when red blood cells are deficient in the enzyme
- Type 2 (generalized reductase deficiency) occurs when the enzyme does not work in the body
2. In autosomal dominant methemoglobinemia one parent is the carrier. The disease is caused by defects in the protein hemoglobin.Autosomal dominant methemoglobinemia is also known as hemoglobin M disease.
Acquired methemoglobinemia is usually the most common form. It happens when people are exposed to chemicals, drugs and certain foods. Some of the causes include:
- Anesthetics like benzocaine or lidocaine (in excess)
- Antibiotics like chloroquine
Symptoms of inherited Type 1 methemoglobinemia and hemoglobin M disease usually manifest in bluish skin color.
Symptoms of inherited Type 2 methemoglobinemia include:
- Failure of infants and children to thrive
- Developmental delays
- Intellectual disability
- Epileptic seizures
Symptoms of acquired methemoglobinemia include:
- Bluish skin color
- Breathing trouble
- Low energy
Some of the diagnostics used include:
- Complete blood counts (CBC), reticulocyte counts
- Liver function tests, electrolytes
- Hemoglobin electrophoresis for hemoglobin M disease. In some cases, an exome mapping may be required
- Enzyme assays
- Nitrite levels
To determine how efficiently oxygen is carried in the blood, other tests like arterial blood gas (ABG), co-oximetry and pulse oximetry may be done.
Usually a potassium cyanide test is also done to distinguish between methemoglobin and sulfhemoglobin.
Early clinical intervention is important to avoid fatalities. Severe methemoglobinemia is usually an emergency requiring immediate clinical management. There is no specified pharmacologic treatment for the hereditary methemoglobinemia.
The first step in managing methemoglobinemia should include:
- Supplementary oxygen
- Diagnosing the causative factor
- Tackling the main cause
The main treatment modalities include:
- Methylene blue which is usually the first line of treatment. However this is contraindicated in G6PD deficiency and usually ineffective for hemoglobin M
- Exchange transfusion (removing the patientís blood and replacing with donated blood) is useful for those patients who do not respond to methylene blue therapy
- Hyperbaric oxygen therapy where the patient breathes pure oxygen in a pressurized room
- IV rehydration to replenish electrolyte loss
- Other medications which include ascorbic acid, riboflavin
- Dietary control
People with Type 1 and hemoglobin M usually sustain and thrive well. Type 2 is more serious and fatal resulting in early death.
- Methemoglobinemia - (https://www.nlm.nih.gov/medlineplus/ency/article/000562.htm)
- Methemoglobinemia: from diagnosis to treatment - (http://www.scielo.br/scielo.php?pid=s0034-70942008000600011&script=sci_arttext&tlng=en)
- Methemoglobinemia and Medications A to Z - (http://www.dpic.org/article/professional/methemoglobinemia-and-medications-z)
- Methemoglobinemia: diagnosis - (https://www.openanesthesia.org/methemoglobinemia_diagnosis/)
- Exchange transfusion - (https://www.nlm.nih.gov/medlineplus/ency/article/002923.htm)
- Hyperbaric oxygen therapy - (http://www.mayoclinic.org/tests-procedures/hyperbaric-oxygen-therapy/basics/definition/prc-20019167)
- Methemoglobinemia - (http://emedicine.medscape.com/article/204178-overview)
- What is G6PD Deficiency - (http://www.g6pd.org/g6pddeficiency.aspx)
- Methemoglobinemia, beta-globin type - (http://ghr.nlm.nih.gov/condition/methemoglobinemia-beta-globin-type)
Please use one of the following formats to cite this article in your essay, paper or report:
Dr. Namitha A Kumar. (2015, November 05). Methemoglobinemia - Causes, Symptoms, Diagnosis, Treatment, Prognosis. Medindia. Retrieved on Feb 04, 2023 from https://www.medindia.net/patients/patientinfo/methemoglobinemia.htm.
Dr. Namitha A Kumar. "Methemoglobinemia - Causes, Symptoms, Diagnosis, Treatment, Prognosis". Medindia. Feb 04, 2023. <https://www.medindia.net/patients/patientinfo/methemoglobinemia.htm>.
Dr. Namitha A Kumar. "Methemoglobinemia - Causes, Symptoms, Diagnosis, Treatment, Prognosis". Medindia. https://www.medindia.net/patients/patientinfo/methemoglobinemia.htm. (accessed Feb 04, 2023).
Dr. Namitha A Kumar. 2021. Methemoglobinemia - Causes, Symptoms, Diagnosis, Treatment, Prognosis. Medindia, viewed Feb 04, 2023, https://www.medindia.net/patients/patientinfo/methemoglobinemia.htm.
Latest Publications and Research on Methemoglobinemia
- Differential effect of catechin hydrate and caffeine and it's metabolite on prevention of methemoglobinemia caused by nitrate and nitrite containing drugs used for the treatment of coronary heart disease. - Published by PubMed
- Clinical characteristics on manifestation and gene mutation of a transient neonatal cyanosis: A case report. - Published by PubMed
- A severe case of methaemoglobinaemia in a Brazilian hairdresser. - Published by PubMed
- Lethal methemoglobinemia in the invasive brown treesnake after acetaminophen ingestion. - Published by PubMed
- Murphy's law in force: sequential adverse events encountered during the treatment of Pneumocystis pneumonia (cotrimoxazole-induced acute peripheral neuropathy and primaquine-induced methemoglobinemia). - Published by PubMed